×
Join our live online event
How top hedge funds use news to make money
form the stock market & how ordinary people are
copying their strategies
Register now!
form the stock market & how ordinary people are
copying their strategies
No thanks
IMRX – immuneering corporation - class a (US:NASDAQ)
DELAYED
$
| Volume Shares | |
| 1 Day Range | |
| Volume Ratio | |
| 52 Week High | |
| 52 Week Low |
| VWAP | |
| Today’s Volatility | |
| 20 Days Volatility | |
| Open | |
| Prior Close |
1D
5D
1M
3M
YTD
1Y
3Y
1 Day
IMRX
SPY
QQQ
Swipe to see more
Main News & Impact Reports
Date
Time
Symbol
Headline
Impact
4/20
09:12 am
imrx
Immuneering Presents Genetic Data at AACR Annual Meeting Demonstrating Mechanism to Improve Durability and Survival, Supporting Use of Atebimetinib in First-Line Pancreatic Cancer and Beyond [Yahoo! Finance]
Medium
Report
Immuneering Presents Genetic Data at AACR Annual Meeting Demonstrating Mechanism to Improve Durability and Survival, Supporting Use of Atebimetinib in First-Line Pancreatic Cancer and Beyond [Yahoo! Finance]
4/20
09:00 am
imrx
Immuneering Presents Genetic Data at AACR Annual Meeting Demonstrating Mechanism to Improve Durability and Survival, Supporting Use of Atebimetinib in First-Line Pancreatic Cancer and Beyond
Medium
Report
Immuneering Presents Genetic Data at AACR Annual Meeting Demonstrating Mechanism to Improve Durability and Survival, Supporting Use of Atebimetinib in First-Line Pancreatic Cancer and Beyond
4/19
01:03 am
imrx
Immuneering (IMRX) was upgraded by Wall Street Zen from "sell" to "ho
Medium
Report
Immuneering (IMRX) was upgraded by Wall Street Zen from "sell" to "ho
4/14
03:16 am
imrx
Immuneering CEO Touts 64% 12-Month Survival in Pancreatic Cancer; Phase 3 Launch Nears [Yahoo! Finance]
Medium
Report
Immuneering CEO Touts 64% 12-Month Survival in Pancreatic Cancer; Phase 3 Launch Nears [Yahoo! Finance]
4/11
01:00 am
imrx
Immuneering (IMRX) was downgraded by Wall Street Zen from "hold" to "
Medium
Report
Immuneering (IMRX) was downgraded by Wall Street Zen from "hold" to "
4/6
04:05 pm
imrx
Immuneering to Present at the 25th Annual Needham Virtual Healthcare Conference
Medium
Report
Immuneering to Present at the 25th Annual Needham Virtual Healthcare Conference
3/17
05:14 pm
imrx
Immuneering to Present Molecular Data at 2026 AACR Annual Meeting from Atebimetinib-Treated Patients, Highlighting Mechanism Designed to Improve Durability and Survival [Yahoo! Finance]
Low
Report
Immuneering to Present Molecular Data at 2026 AACR Annual Meeting from Atebimetinib-Treated Patients, Highlighting Mechanism Designed to Improve Durability and Survival [Yahoo! Finance]
3/17
04:35 pm
imrx
Immuneering to Present Molecular Data at 2026 AACR Annual Meeting from Atebimetinib-Treated Patients, Highlighting Mechanism Designed to Improve Durability and Survival
Low
Report
Immuneering to Present Molecular Data at 2026 AACR Annual Meeting from Atebimetinib-Treated Patients, Highlighting Mechanism Designed to Improve Durability and Survival
Date
Time
Symbol
Company Name
Action
%Chg
11/12/2025
04:05 pm
IMRX
immuneering corporation - class a
MISS
Report
-0.3%
immuneering corporation - class a
8/13/2025
04:05 pm
IMRX
immuneering corporation - class a
IN-LINE
Report
-3.8%
immuneering corporation - class a
5/5/2025
04:05 pm
IMRX
immuneering corporation - class a
MISS
Report
-4.8%
immuneering corporation - class a
Date
Time
Symbol
Headline
Impact
3/17
04:47 pm
imrx
Form 4 Immuneering Corp For: Mar 13 Filed by: Neufeld Leah R
Low
Report
Form 4 Immuneering Corp For: Mar 13 Filed by: Neufeld Leah R
3/6
08:29 am
imrx
Form 10-K Immuneering Corp For: Dec 31
Medium
Report
Form 10-K Immuneering Corp For: Dec 31
3/6
08:09 am
imrx
Form 8-K Immuneering Corp For: Mar 06
Medium
Report
Form 8-K Immuneering Corp For: Mar 06
2/5
08:45 am
imrx
Form 4 Immuneering Corp For: Feb 03 Filed by: Bookman Michael
Medium
Report
Form 4 Immuneering Corp For: Feb 03 Filed by: Bookman Michael
2/5
08:38 am
imrx
Form 4 Immuneering Corp For: Feb 03 Filed by: Brakewood Harold Eugene
Medium
Report
Form 4 Immuneering Corp For: Feb 03 Filed by: Brakewood Harold Eugene
2/5
08:33 am
imrx
Form 4 Immuneering Corp For: Feb 03 Filed by: Hall Brett Matthew
Medium
Report
Form 4 Immuneering Corp For: Feb 03 Filed by: Hall Brett Matthew
2/5
08:27 am
imrx
Form 4 Immuneering Corp For: Feb 03 Filed by: Matushansky Igor
Medium
Report
Form 4 Immuneering Corp For: Feb 03 Filed by: Matushansky Igor
2/5
08:23 am
imrx
Form 4 Immuneering Corp For: Feb 03 Filed by: Morales Mallory
Medium
Report
Form 4 Immuneering Corp For: Feb 03 Filed by: Morales Mallory
Stock Stats
| News Stats | |
|---|---|
| All News | |
| News Wires | |
| Media Monitoring | |
| SEC Edgar Filings | |
| Upgrades | |
| Downgrades | |
| Initiated | |
| Reiterated | |
| Last Earnings | |
| Last Earnings EPS | |
| Next Earnings | |
| Order Stats |
|---|
| Sub-Penny |
|
|
| Odd lot |
|
|
| Avg. bid-ask spread |
|
|
| Avg. bid-ask size |
|
|
| Shares at ask/bid |
|
|
| Off exchange |
|
|
Main News & Impact Reports
TOP News Gainers
TOP News Decliners
Don’t Miss Out On The Next BIG Stock Move
Never get left behind with our daily ‘Shakers & Movers’ newsletter. Discover the biggest gainer or loser in the stock market, and learn exactly WHY it moved. To find out which one caught Wall Street by surprise TODAY, sign up to our newsletter below: